Whether the spectacular preclinical pharmacology of GLP-1R/GcgR co-agonists will translate through successful phase 3 registration trials is a question that will be answered in the coming years, but the pursuit of multifunctional, targeted therapeutics is destined to continue
If you take insulin for diabetes, let your doctor know before you take phentermine, as you may need to adjust your insulin dose
Vilka rttigheterhar du
Protecting your hair if you restart or change GLP-1 medications Switching from one GLP-1 medication to another, or restarting after a break, carries a theoretical risk of triggering another round of telogen effluvium, particularly if the new medication or restart leads to another phase of rapid weight loss
Kawai T, Sun B, Yoshino H, Feng D, Suzuki Y, Fukazawa M, et al
Timing of these treatments is very important